Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Innovations in Hepatitis C Screening and Treatment.
Patel AA, Bui A, Prohl E, Bhattacharya D, Wang S, Branch AD, Perumalswami PV. Patel AA, et al. Among authors: perumalswami pv. Hepatol Commun. 2020 Dec 7;5(3):371-386. doi: 10.1002/hep4.1646. eCollection 2021 Mar. Hepatol Commun. 2020. PMID: 33681673 Free PMC article. Review.
Diabetes mellitus and advanced liver fibrosis are risk factors for severe anaemia during telaprevir-based triple therapy.
Crismale JF, Martel-Laferrière V, Bichoupan K, Schonfeld E, Pappas A, Wyatt C, Odin JA, Liu LU, Schiano TD, Perumalswami PV, Bansal M, Dieterich DT, Branch AD. Crismale JF, et al. Among authors: perumalswami pv. Liver Int. 2014 Aug;34(7):1018-24. doi: 10.1111/liv.12342. Epub 2013 Oct 25. Liver Int. 2014. PMID: 24118693 Free PMC article.
Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir.
Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Bichoupan K, et al. Aliment Pharmacol Ther. 2014 Jan;39(2):209-16. doi: 10.1111/apt.12560. Epub 2013 Nov 24. Aliment Pharmacol Ther. 2014. PMID: 24266536 Free PMC article.
Commentary: real-world triple therapy experience treating hepatitis C virus - authors' reply.
Bichoupan K, Schwartz JM, Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H, Dieterich DT, Branch AD, Reinus JF. Bichoupan K, et al. Aliment Pharmacol Ther. 2014 Mar;39(5):543. doi: 10.1111/apt.12641. Aliment Pharmacol Ther. 2014. PMID: 24494843 Free article. No abstract available.
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response.
Bichoupan K, Martel-Laferriere V, Sachs D, Ng M, Schonfeld EA, Pappas A, Crismale J, Stivala A, Khaitova V, Gardenier D, Linderman M, Perumalswami PV, Schiano TD, Odin JA, Liu L, Moskowitz AJ, Dieterich DT, Branch AD. Bichoupan K, et al. Among authors: perumalswami pv. Hepatology. 2014 Oct;60(4):1187-95. doi: 10.1002/hep.27340. Epub 2014 Aug 25. Hepatology. 2014. PMID: 25065814 Free PMC article.
89 results